The MRDR supports Rare Disease Day 2024.
The MRDR supports World Cancer Day.
Sueh-li Lim's paper on Real-world outcomes in relapsed refractory multiple myeloma patients exposed to three or more prior treatments has been published.
The MRDR was well-represented at Blood 2023!
The MRDR had the opportunity to for two poster presentations at the International Myeloma Society Annual meeting in Athens.
The MRDR reaches another milestone of recruiting more than 6500 patients!
Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.
The MRDR recruits another hospital for the Myeloma 1000 Project.
MY-PROMPT-2 project randomises first patient and enrols another!
Ken Lim's paper on Inferior outcomes in t(11;14) multiple myeloma has been accepted for publication.